Docket #: S05-206
Fluorescent Cell Barcoding (FCB) in Flow Cytometry to Enable High-Throughput Drug Screening and Large-Scale Signaling Profiling
Applications
- High-throughput screening in drug development
- Large-scale signaling profiling
Advantages
- Increased throughput, compared to current methods in flow cytometry, with an acquisition time of 5-15 minutes per 96-well plate
- Decreased cost in sample labeling with 100-fold reduced antibody consumption
Publications
- Krutzik PO and Nolan GP, "Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling." Nature Methods 3, 361 - 368 (2006)
Patents
- Published Application: 20080241820
- Published Application: 20110263457
- Issued: 8,003,312 (USA)
Similar Technologies
-
Methods enabling infection and differentiation of human distal lung organoids by SARS-CoV-2 and other pathogens S20-312Methods enabling infection and differentiation of human distal lung organoids by SARS-CoV-2 and other pathogens
-
Microfluidics device for high-throughput liquid biopsy and other cellular analyses S17-169Microfluidics device for high-throughput liquid biopsy and other cellular analyses
-
Ex vivo expansion and culture of intestinal epithelium S06-394Ex vivo expansion and culture of intestinal epithelium